Akkad A A, Habiba M A, Ismail N, Abrams K, al-Azzawi F
Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Leicester, United Kingdom.
Obstet Gynecol. 1995 Sep;86(3):330-4. doi: 10.1016/0029-7844(95)00172-N.
To examine the importance of submucous myomas and endometrial polyps before and after menopause and in abnormal withdrawal bleeding on hormone replacement therapy (HRT).
Between May 1991 and May 1993, women presenting with abnormal withdrawal bleeding on HRT (n = 106), menstrual problems in pre-menopause (n = 92), or postmenopausal bleeding (n = 33) underwent diagnostic outpatient hysteroscopy for the presence of intrauterine structural abnormalities. The findings were compared with a control group of post- and perimenopausal women without bleeding problems (n = 183).
When compared with women who had normal uterine cavities, the presence of submucous myomas was associated with a threefold increase in the risk of abnormal menstrual bleeding in premenopausal women (odds ratio [OR] 3.34, 95% confidence interval [CI] 1.77-6.43; P < .001) and a twofold increase in the risk of abnormal withdrawal bleeding in post- and perimenopausal women (OR 2.4, 95% CI 1.25-4.53; P = .004). This did not seem to be related to the number of myomas detected. The frequency of endometrial polyps was not found to be significantly higher in women who had menstrual disorders or abnormal withdrawal bleeding on HRT. Postmenopausal bleeding without hormonal stimulation was not significantly associated with submucous myomas or polyps.
As increasingly more women request HRT, bleeding problems presenting pre-menopause can no longer be expected to resolve "naturally" after menopause. In the presence of submucous myomas, these women will continue to have a higher risk of abnormal withdrawal bleeding when treated with hormone replacement, whereas endometrial polyps are not associated with an increased bleeding risk. Hysteroscopic assessment of the uterine cavity and subsequent counseling as to the risk of heavy or prolonged bleeding will be helpful in their future management and may improve compliance.
探讨绝经前后黏膜下肌瘤和子宫内膜息肉以及激素替代疗法(HRT)中异常撤退性出血的重要性。
1991年5月至1993年5月,因HRT出现异常撤退性出血的女性(n = 106)、绝经前月经问题的女性(n = 92)或绝经后出血的女性(n = 33)接受诊断性门诊宫腔镜检查以确定子宫内结构异常情况。将检查结果与无出血问题的绝经后及围绝经期女性对照组(n = 183)进行比较。
与子宫腔正常的女性相比,黏膜下肌瘤的存在使绝经前女性月经异常出血风险增加两倍(比值比[OR] 3.34,95%置信区间[CI] 1.77 - 6.43;P <.001),使绝经后及围绝经期女性异常撤退性出血风险增加一倍(OR 2.4,95% CI 1.25 - 4.53;P =.004)。这似乎与检测到的肌瘤数量无关。未发现HRT时出现月经紊乱或异常撤退性出血的女性中子宫内膜息肉的发生率显著更高。无激素刺激的绝经后出血与黏膜下肌瘤或息肉无显著关联。
随着越来越多的女性要求进行HRT,绝经前出现的出血问题不能再期望绝经后“自然”解决。存在黏膜下肌瘤时,这些女性接受激素替代治疗时异常撤退性出血风险仍会更高,而子宫内膜息肉与出血风险增加无关。宫腔镜评估子宫腔并随后就严重或长期出血风险提供咨询,将有助于她们未来的管理并可能提高依从性。